Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. [Phase 2, Phase 3]
Clinical trial update on the safety and efficacy of EIK1001 in combination with pembrolizumab and chemotherapy for Stage 4 non-small cell lu…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Optimizing Endobronchial Ultrasound Sampling for Molecular Markers for NSCLC [NA]
A clinical trial update describing efforts to optimize endobronchial ultrasound sampling for detecting molecular markers in non-small cell l…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study [Phase 2]
Phase 2 trial evaluating furmonertinib at 160 mg versus 80 mg with chemotherapy in EGFR-mutated non-small cell lung cancer with brain metast…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial) [Phase 2, Phase 3]
An ongoing Phase 2/3 trial in an expanded Lung-MAP study evaluating cemiplimab added to standard treatment for advanced non-small cell lung …
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial) [Phase 2]
SWOG's expanded Lung-MAP trial is evaluating a targeted therapy for advanced non-small cell lung cancer with MET exon 14 skipping mutations;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4) [Phase 3]
Phase 3 trial DUBLIN-4 compares docetaxel plus plinabulin vs docetaxel plus placebo in advanced/metastatic non-squamous non-small cell lung …
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer [Phase 2]
This entry reports a Phase 2 trial evaluating adjunctive intravenous ascorbic acid for advanced non-small cell lung cancer, which is current…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Phase Ⅰ/Ⅱa Clinical Study of GEN-725 in Combination With Dositinib [Phase 1, Phase 2]
A Phase 1/2a clinical study evaluating GEN-725 in combination with Dositinib is currently recruiting for non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer [NA]
This item reports an ongoing clinical trial at Thomas Jefferson University examining the impact of surgical technique on circulating tumor D…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer. [Phase 3]
This update notes a Phase 3 trial evaluating SCTB14 as first-line therapy for non-small cell lung cancer, which is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2, Phase 3]
A study to determine whether adding fianlimab to cemiplimab improves outcomes versus cemiplimab alone in adults with advanced non-small cell…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: First in Human Study of QLS5316 in Solid Tumors [Phase 1]
This is a first-in-human Phase 1 trial of QLS5316 in various solid tumors; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer [NA]
A completed clinical trial examining the relationship between circulating immune cells and the tumor immune contexture in patients with rese…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer [Phase 2]
A Phase 2 trial assessing osimertinib plus selumetinib in EGFR-mutant, EGFR-inhibitor naive advanced non-small cell lung cancer is currently…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Phase l Clinical Study to Evalute the Safety,Tolerability,Pharmacokinetic Characteristics,and Preliminary Anti-tumor Efficacy of HJ-004-02 Tablets in Patients With Non-squamous Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutations [Phase 1]
Phase 1 trial evaluating safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of HJ-004-02 tablets in patients with n…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating OCT-598 in patients with advanced solid tumors; the study is currently recruiting and includes multiple tu…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer [Phase 2, Phase 3]
This entry reports an ongoing Phase 2/Phase 3 clinical trial evaluating the combination of fianlimab with cemiplimab and chemotherapy versus…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLC [Phase 2]
Phase II trial evaluating HLX43 plus serplulimab as neoadjuvant therapy for non-small cell lung cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating toripalimab in combination with platinum-based chemotherapy, with or without an H1 receptor antagonist, as…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI [Phase 1, Phase 2]
This clinical trial update reports an early-phase study evaluating lung functional avoidance radiotherapy guided by hyperpolarized xenon MRI…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cancer With HER2 Mutations [Phase 3]
A Phase 3 clinical trial of SHR-A1811 is ongoing as first-line treatment for advanced or metastatic non-small cell lung cancer with HER2 mut…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimertinib.
Australian retrospective analysis of patients with EGFR-mutant advanced or metastatic non-small cell lung cancer treated with first- or seco…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating first-line combination of ipilimumab, nivolumab, and N-803 for stage IV or recurrent non-small cell lung cancer; th…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients [NA]
A prospective, longitudinal biocollection in thoracic oncology enrolling newly diagnosed lung cancer patients to collect biological samples …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors [Phase 1]
Phase 1 study of GNC-077 in patients with non-small cell lung cancer and other solid tumors, currently recruiting.